Lung Cancers Completed Phase 2 Trials for Budesonide (DB01222)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00321893Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung CancerPrevention
NCT00005880Budesonide in Treating Former and Current Smokers With Bronchial DysplasiaPrevention